Home › Funds › PERCEPTIVE ADVISORS LLC › JAZZ
PERCEPTIVE ADVISORS LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
PERCEPTIVE ADVISORS LLC reported holding 170,000 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$41.0M, representing 0.65% of its reported portfolio and ranking #34 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed JAZZ holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's JAZZ position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in JAZZ in Q4 2025 at 170,000 shares (US$28.9M). The position peaked in Q2 2026 at 170,000 shares, worth US$41.0M. Across 3 filings, PERCEPTIVE ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 170,000 shares valued at US$41.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 170.00K | $28.90M | New |
| Q1 2026 | 170.00K | $32.14M | Hold |
| Q2 2026 | 170.00K | $40.96M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
- Sofinnova Investments, Inc. 365.34K sh · $88.04M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held JAZZ?
PERCEPTIVE ADVISORS LLC has disclosed JAZZ holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is PERCEPTIVE ADVISORS LLC's current position in JAZZ?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 170.00K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $40.96M, representing 0.65% of its reported portfolio and ranking #34.
Has PERCEPTIVE ADVISORS LLC been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC held unchanged its position in JAZZ. The position peaked in Q2 2026 at 170.00K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.